W e thank Bolland and colleagues for engaging in a dialog on an important issue. In essence, their letter raises two important and contentious issues in clinical trialing, the selection of safety endpoints and the power of the study. Endpoint selection: As noted by a recent BMJ review of the topic
✦ LIBER ✦
Calcium supplements and cardiovascular disease – A response
✍ Scribed by G. Jackson
- Book ID
- 111309535
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 111 KB
- Volume
- 65
- Category
- Article
- ISSN
- 1368-5031
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Response to “calcium supplements and car
✍
Joshua R Lewis; Janine Calver; Kun Zhu; Leon Flicker; Richard L Prince
📂
Article
📅
2011
🏛
American Society for Bone and Mineral Research
🌐
English
⚖ 45 KB
Calcium supplements and cardiovascular d
✍
A. Grey; M. Bolland; R. Reid
📂
Article
📅
2011
🏛
John Wiley and Sons
🌐
English
⚖ 139 KB
Calcium supplements and cardiovascular r
✍
Mark J Bolland; Andrew Grey; Ian R Reid
📂
Article
📅
2011
🏛
American Society for Bone and Mineral Research
🌐
English
⚖ 32 KB
Lewis and colleagues report that calcium supplements had no effect on the incidence of atherosclerotic vascular disease. (1) We do not agree that these results differ from previous studies or provide ''compelling evidence'' of the cardiovascular safety of calcium supplements. Instead, these findings
Dietary supplements and cardiovascular d
✍
Ruth M. DeBusk
📂
Article
📅
2000
🏛
Current Science Inc.
🌐
English
⚖ 284 KB
Nutritional Supplements and Cardiovascul
✍
Avni Sali; Luis Vitetta
📂
Article
📅
2004
🏛
Elsevier Science
🌐
English
⚖ 94 KB
Calcium and vitamin D supplementation an
✍
T.J. Aspray; R.M. Francis
📂
Article
📅
2011
🏛
Elsevier Science
🌐
English
⚖ 127 KB